Biomea Fusion, Inc. (BMEA)
1.27
-0.03
(-2.31%)
USD |
NASDAQ |
Oct 02, 16:00
1.275
0.00 (0.00%)
After-Hours: 20:00
Biomea Fusion Price to Book Value : 7.585 for Oct. 2, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 7.585 |
| October 01, 2026 | 7.764 |
| September 30, 2026 | 7.943 |
| September 29, 2026 | 7.525 |
| September 28, 2026 | 7.704 |
| September 25, 2026 | 7.883 |
| September 24, 2026 | 8.899 |
| September 23, 2026 | 8.600 |
| September 22, 2026 | 10.15 |
| September 21, 2026 | 10.21 |
| September 18, 2026 | 10.93 |
| September 17, 2026 | 10.69 |
| September 16, 2026 | 10.39 |
| September 15, 2026 | 10.75 |
| September 14, 2026 | 10.63 |
| September 11, 2026 | 10.39 |
| September 10, 2026 | 10.15 |
| September 09, 2026 | 11.02 |
| September 08, 2026 | 11.53 |
| September 04, 2026 | 12.12 |
| September 03, 2026 | 11.41 |
| September 02, 2026 | 11.56 |
| September 01, 2026 | 10.75 |
| August 31, 2026 | 10.03 |
| August 28, 2026 | 10.33 |
| Date | Value |
|---|---|
| August 27, 2026 | 10.03 |
| August 26, 2026 | 10.21 |
| August 25, 2026 | 10.33 |
| August 24, 2026 | 9.496 |
| August 21, 2026 | 8.182 |
| August 20, 2026 | 8.122 |
| August 19, 2026 | 8.302 |
| August 18, 2026 | 8.063 |
| August 17, 2026 | 8.063 |
| August 14, 2026 | 7.883 |
| August 13, 2026 | 7.644 |
| August 12, 2026 | 7.644 |
| August 11, 2026 | 7.704 |
| August 10, 2026 | 7.585 |
| August 07, 2026 | 7.525 |
| August 06, 2026 | 7.465 |
| August 05, 2026 | 7.525 |
| August 04, 2026 | 7.346 |
| August 03, 2026 | 7.167 |
| July 31, 2026 | 6.988 |
| July 30, 2026 | 7.286 |
| July 29, 2026 | 7.286 |
| July 28, 2026 | 7.465 |
| July 27, 2026 | 7.525 |
| July 24, 2026 | 7.465 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| REGENXBIO, Inc. | 5.608 |
| Compass Therapeutics, Inc. | 0.9291 |
| ACADIA Pharmaceuticals, Inc. | 2.628 |
| Alnylam Pharmaceuticals, Inc. | 21.70 |
| Savara, Inc. | 6.877 |
Price to Book Value Related Metrics
| Price | 1.27 |
| Earnings Yield | -39.14% |
| Market Cap | 92.05M |